skip to primary navigationskip to content
 

Neuronal reward processing, learning and neuroeconomics

Supervisor: Wolfram Schultz

Rewards produce learning, constitute goals of behaviour and are outcomes of decisions. We investigate reward issues in individuals acting on their own and in social contexts. We investigate main reward structures, including dopamine neurons, striatum, amygdala, orbitofrontal, cingulate and dorsolateral prefrontal cortex. We achieve these aims with neurophysiological experiments in animals performing controlled tasks designed on the basis of psychological learning theories and economic decision theories. Closely related neuroimaging experiments extend this work to humans. This research will reveal basic reward, risk and decision signals, impact on theories of normal behaviour and provide necessary knowledge for investigating pathological reward and risk processes in addiction, gambling and mental disorders. Desired knowledge by PhD candidates would be as much as possible of the following list: quantitative behavioural testing, psychophysics, basic knowledge in Matlab or similar computer language (Pascal, C++, Fortran, Pyton, etc), good capture of systems neuroscience, electrophysiology or fMRI imaging.

Relevant references

Stauffer, Lak & Schultz, Current Biology 24: 2491-2500, 2014 (neuronal utility signal).

Genest, Stauffer & Schultz, PNAS 113: 8402-8407, 2016 (behavioural risk attitude).

Zangemeister, Grabenhorst & Schultz, Current Biology 2016 in press (human imaging of economic saving sequences).

 

RSS Feed Latest news

Magdalena Zernicka-Goetz awarded international IVI Foundation Award

Apr 21, 2017

Prof Zernicka-Goetz was awarded the IVI Foundation Award for Basic Research in Reproductive Medicine 2017.

Algorithm matches genetic variation to disease symptoms and could improve diagnosis of rare diseases

Apr 21, 2017

A faster and more accurate method of identifying which of an individual’s genes are associated with particular symptoms has been developed by a team of researchers from the UK and Saudi Arabia. This new approach could enable scientists to take advantage of recent developments in genome sequencing to improve diagnosis and potential treatment options.

View all news